Key Points
- Cigna CEO David Cordani sold 201,878 shares on May 12 at an average price of $292.82, generating about $59.1 million. After the sale, he still owned 34,337 shares, and the transaction was made under a pre-arranged Rule 10b5-1 plan.
- Cigna beat quarterly expectations in its latest earnings report, posting $7.79 EPS versus the $7.60 consensus and revenue of $68.52 billion versus expectations of $66.29 billion. Revenue rose 4.6% year over year.
- The company maintained a shareholder-friendly outlook by announcing a quarterly dividend of $1.56 per share, equal to $6.24 annually and a 2.1% yield. Analysts remain mostly bullish, with a consensus rating of “Moderate Buy” and an average price target of $338.35.
Cigna Group (NYSE:CI - Get Free Report) CEO David Cordani sold 201,878 shares of the business's stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company's stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Cigna Group Price Performance
Shares of NYSE:CI opened at $294.39 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock has a market cap of $77.87 billion, a price-to-earnings ratio of 12.48, a PEG ratio of 1.05 and a beta of 0.30. The stock's 50 day moving average price is $274.94 and its 200 day moving average price is $275.90. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.
Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts' expectations of $66.29 billion. During the same quarter in the previous year, the company earned $6.74 earnings per share. The firm's quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group's payout ratio is presently 26.45%.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP bought a new position in shares of Cigna Group in the fourth quarter valued at $28,000. Kemnay Advisory Services Inc. bought a new position in shares of Cigna Group in the fourth quarter valued at $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group during the 4th quarter worth approximately $29,000. Finally, Cedar Mountain Advisors LLC grew its position in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Institutional investors own 86.99% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Guggenheim boosted their target price on Cigna Group from $334.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Leerink Partners boosted their target price on Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a report on Friday, February 6th. Jefferies Financial Group dropped their target price on Cigna Group from $333.00 to $330.00 and set a "buy" rating on the stock in a report on Monday, April 20th. Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. Finally, Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $338.35.
Get Our Latest Stock Report on CI
About Cigna Group
(
Get Free Report)
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
